Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,749,771
  • Shares Outstanding, K 61,278
  • Annual Sales, $ 18,660 K
  • Annual Income, $ -132,690 K
  • 60-Month Beta 1.51
  • Price/Sales 355.81
  • Price/Cash Flow N/A
  • Price/Book 34.03

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 2.36
  • Number of Estimates 3
  • High Estimate 8.22
  • Low Estimate -0.73
  • Prior Year -1.03
  • Growth Rate Est. (year over year) +329.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.22 +34.14%
on 09/08/20
132.80 -15.94%
on 08/24/20
-25.99 (-18.89%)
since 08/21/20
3-Month
62.94 +77.36%
on 06/23/20
189.40 -41.06%
on 08/05/20
+45.68 (+69.26%)
since 06/22/20
52-Week
3.54 +3,053.39%
on 11/21/19
189.40 -41.06%
on 08/05/20
+105.08 (+1,604.27%)
since 09/20/19

Most Recent Stories

More News
4 Biotechs That Have More Than Doubled Thanks to Coronavirus

Stocks of several small biotech companies more than double so far this year as they taste success in their efforts to make a vaccine/medicine for treating COVID-19.

JNJ : 144.21 (-0.61%)
PFE : 36.25 (+0.64%)
MRNA : 68.72 (-0.78%)
GSK : 38.00 (-0.55%)
NVAX : 111.63 (+1.34%)
VIR : 32.89 (+2.78%)
BNTX : 67.05 (+1.41%)
Novavax (NVAX) Gains As Market Dips: What You Should Know

Novavax (NVAX) closed the most recent trading day at $110.15, moving +1.65% from the previous trading session.

NVAX : 111.63 (+1.34%)
Top Biotech Stocks To Watch In Q4 2020

These Biotech Stocks Are At The Forefront of Medical Innovation.

ISRG : 666.02 (+3.75%)
NVAX : 111.63 (+1.34%)
PFE : 36.25 (+0.64%)
CRSP : 88.81 (+4.32%)
VRTX : 267.58 (+1.36%)
Diagnostic Devices Give the Healthcare System New Avenues for Innovation

, /PRNewswire/ -- The recent pandemic, which has put a heavy toll on our economy and pushed the healthcare system into a severe scarcity problem, further illustrates the importance of medical devices...

OPK : 3.22 (-0.92%)
NMRD : 3.64 (-0.27%)
IBIO : 2.27 (-6.58%)
CODX : 14.93 (-1.58%)
NVAX : 111.63 (+1.34%)
Novavax Expands Coronavirus Vaccine Manufacturing Deal in India

Novavax (NVAX) amends its present contract with Serum Institute of India Private Limited to widen the manufacturing capacity of its COVID-19 vaccine candidate NVX-CoV2373 to 2 billion plus doses in 2021....

AZN : 55.44 (-0.84%)
PFE : 36.25 (+0.64%)
MRNA : 68.72 (-0.78%)
NVAX : 111.63 (+1.34%)
Nanomedicine Seen As A Promising Approach For Diagnosis and Treatment Against COVID

PLAM BEACH, Fla., /PRNewswire/ -- The National Institute for Health (NIH) is at the heart of the emerging and rapidly evolving war against the global pandemic. They constantly update the public on the...

NNVC : 4.00 (-0.99%)
IMMU : 85.05 (-0.42%)
GILD : 63.40 (-1.26%)
INO : 16.98 (-4.01%)
NVAX : 111.63 (+1.34%)
What Are The Best Biotech Stocks To Watch Before Friday? 3 To Know

Are These Biotech Stocks Worth The Attention Now?

SRNE : 10.78 (+10.51%)
VIR : 32.89 (+2.78%)
INO : 16.98 (-4.01%)
MRNA : 68.72 (-0.78%)
NVAX : 111.63 (+1.34%)
Vaxart Gets FDA Nod for Phase I Study on Coronavirus Vaccine

Vaxart's (VXRT) investigational new drug application for oral coronavirus vaccine candidate gets a clearance from the FDA. The company will begin a phase I study later this month.

MRNA : 68.72 (-0.78%)
NVAX : 111.63 (+1.34%)
EBS : 100.75 (+0.75%)
VXRT : 8.75 (-2.67%)
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax' Global Production Capacity to Over 2 Billion Doses Annually

- Serum Institute of India to manufacture ~1 billion doses of NVX-CoV2373 in 2021

NVAX : 111.63 (+1.34%)
Novavax Inc Rises 5.19% on Heavy Volume: Watch For Potential Pullback

Novavax Inc (NASDAQ:NVAX) traded in a range yesterday that spanned from a low of $94.50 to a high of $100.89. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $99.41...

NVAX : 111.63 (+1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade NVAX with:

Business Summary

NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as...

See More

Key Turning Points

2nd Resistance Point 116.31
1st Resistance Point 113.97
Last Price 111.63
1st Support Level 107.72
2nd Support Level 103.82

See More

52-Week High 189.40
Fibonacci 61.8% 118.40
Last Price 111.63
Fibonacci 50% 96.47
Fibonacci 38.2% 74.54
52-Week Low 3.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar